Cargando…
Updates on Dengue Vaccine and Antiviral: Where Are We Heading?
Approximately 100–400 million people from more than 100 countries in the tropical and subtropical world are affected by dengue infections. Recent scientific breakthroughs have brought new insights into novel strategies for the production of dengue antivirals and vaccines. The search for specific den...
Autores principales: | Norshidah, Harun, Vignesh, Ramachandran, Lai, Ngit Shin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620506/ https://www.ncbi.nlm.nih.gov/pubmed/34833860 http://dx.doi.org/10.3390/molecules26226768 |
Ejemplares similares
-
Assessing the potential of NS2B/NS3 protease inhibitors biomarker in curbing dengue virus infections: In silico vs. In vitro approach
por: Norshidah, Harun, et al.
Publicado: (2023) -
Roles and Prospects of Dengue Virus Non-structural Proteins as Antiviral Targets: An Easy Digest
por: Norazharuddin, Hannah, et al.
Publicado: (2018) -
Animal Sentience: Where are We and Where are We Heading?
por: Proctor, Helen
Publicado: (2012) -
Research Integrity: Where We Are and Where We Are Heading
por: Zhaksylyk, Alikhan, et al.
Publicado: (2023) -
Lifestyle Factors in Cancer Survivorship: Where We Are and Where We Are Headed
por: Vijayvergia, Namrata, et al.
Publicado: (2015)